[18F] -fluorocholin
A radiopharmaceutical, a medicinal product intended for PET/CT examination and diagnosis in the early stages of prostate cancer.
The clinical trial of [18F]-fluorocholine inj was initiated and implemented by CZECRIN in collaboration with the Phase 1 Clinical Trial Unit of the Masaryk Institute of Oncology in Brno and is currently in the registration phase for full clinical use in the Czech Republic.